Treatment of Uncomplicated Gonorrhea
The recommended first-line treatment for uncomplicated gonorrhea is ceftriaxone 500 mg intramuscular (IM) as a single dose. 1, 2
Current Treatment Recommendations
First-Line Regimen
Alternative Regimens (for cephalosporin allergy or unavailability)
Spectinomycin 2 g IM as a single dose 4, 1
- Note: Less effective for pharyngeal infections (only 52% effective) 1
Gentamicin 240 mg IM plus azithromycin 2 g orally as a single dose 1, 5
Important Clinical Considerations
Site-Specific Treatment
- Pharyngeal infections:
Special Populations
- Pregnant patients:
Follow-up
- Patients should abstain from sexual activity until:
- Therapy is completed
- Both patient and partners no longer have symptoms 1
- Retest approximately 3 months after treatment due to high reinfection rates 1
Treatment Pitfalls to Avoid
Do not use quinolones (ciprofloxacin, ofloxacin):
Azithromycin monotherapy is not recommended:
When administering ceftriaxone:
Partner management:
- All sex partners from previous 60 days should be evaluated and treated 1
- Failure to treat partners is a common cause of reinfection
Evolution of Treatment Guidelines
Treatment recommendations have evolved due to antimicrobial resistance patterns:
- Earlier guidelines (2006) included options like cefixime 400 mg orally 4, 7
- Current guidelines (2020-2025) recommend higher doses of ceftriaxone (500 mg vs. previous 250 mg) due to concerns about resistance 1, 2
The shift to ceftriaxone 500 mg IM as the sole first-line agent reflects the urgent need to preserve antibiotic effectiveness against gonorrhea in the face of increasing antimicrobial resistance 2.